Apply today for the HHMI BioInteractive Ambassador Academy! The Academy is a multi-year professional development experience designed to support evidence-based teaching practices. We’re looking for educators with diverse backgrounds and teaching contexts who are committed to centering equity in their classrooms.
The first gene therapy for a deadly form of muscular dystrophy received preliminary U.S. approval on Thursday despite concerns from some government scientists about the treatment’s ability to help boys with the inherited disease.
This interactive tool introduces students to building scientific models. Educators can use the tool to create assignments and, in some cases, automatically grade student models.
This interactive module can be used to model infectious disease spread in a population. It includes background on the SIR model and two simulators for modeling disease spread on different scales.
A new study that analyzes data from more than 50,000 amateur stargazers finds that artificial lighting is making the night sky about 10% brighter each year.
In Virginia’s Elizabeth River, the unremarkable-looking mummichog has survived decades of industrial pollution—but the price it has paid has worrying implications for human health.
With demand for COVID-19 vaccines outpacing the world’s supplies, a frustrated public and policymakers want to know: How can we get more? A lot more. Right away.
In this Click & Learn, students explore mathematical models that describe how populations change over time and apply these models to the invasive lionfish population in the Bahamas. They also use data from other species to learn how density-dependent factors limit population size.
For the first time, a blood test has been shown to help detect many types of cancer in a study of thousands of people with no history or symptoms of the disease.
This video case study explores the approaches scientists used to identify a mutation that causes retinitis pigmentosa (RP), a progressive disease that leads to blindness.
Women who use certain types of hormones after menopause still have an increased risk of developing breast cancer nearly two decades after they stop taking the pills, long-term results from a big federal study suggest.
